Tanshinone IIA suppresses cholesterol accumulation in human macrophages: Role of heme oxygenase-1

Journal of Lipid Research

Volumn 55, Issue 2, 2014, Pages 201-213

  Liu, Zhiping ^a   Wang, Jiaojiao ^a   Huang, Erwen ^b,c   Gao, Si ^a   Li, Hong ^a   Lu, Jing ^a   Tian, Kunming ^d   Little, Peter J ^e   Shen, Xiaoyan ^a   Xu, Suowen ^a,f   Liu, Peiqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangzhou Forensic Science Institute   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^e RMIT UNIVERSITY   (Australia)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

ATP binding cassette transporter A1 G1; Cell signaling; Class A scavenger receptor; Heme catabolism enzyme

Indexed keywords

ATP-BINDING CASSETTE TRANSPORTER A1/G1; CELL SIGNALING; CLASS A SCAVENGER RECEPTOR; HEME CATABOLISM ENZYME;

ANIMALS; ATHEROSCLEROSIS; ATP BINDING CASSETTE TRANSPORTER 1; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CHOLESTEROL; DITERPENES, ABIETANE; DNA; ENZYME ACTIVATION; HEME OXYGENASE-1; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; RECEPTORS, SCAVENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84893426362     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M040394     Document Type: Article

References (52)

1. Li, A. C., and C. K. Glass.2002.The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 8 : 1235-1242.
2. Platt, N., and S. Gordon.2001.Is the class A macrophage scavenger receptor (SR-A) multifunctional? The mouse's tale. J. Clin. Invest. 108 : 649-654.
3. Park, Y. M., M. Febbraio, and R. L. Silverstein.2009.CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J. Clin. Invest. 119 : 136-145.
4. Greaves, D. R., and S. Gordon.2005.The immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J. Lipid Res. 46 : 11-20.
5. Van Eck, M., M. Pennings, M. Hoekstra, R. Out, and T. J. Van Berkel.2005.Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr. Opin. Lipidol. 16 : 307-315.
6. Attie, A. D., J. P. Kastelein, and M. R. Hayden.2001.Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J. Lipid Res. 42 : 1717-1726.
7. Schmitz, G., T. Langmann, and S. Heimerl.2001.Role of ABCG1 and other ABCG family members in lipid metabolism. J. Lipid Res. 42 : 1513-1520.
8. Gao, S., Z. Liu, H. Li, P. J. Little, P. Liu, and S. Xu.2012. Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis.220 : 3-10.
9. Han, J. Y., J. Y. Fan, Y. Horie, S. Miura, D. H. Cui, H. Ishii, T. Hibi, H. Tsuneki, and I. Kimura.2008.Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol. Ther. 117 : 280-295.
10. Xu, S., and P. Liu.2013.Tanshinone II-A: new perspectives for old remedies. Expert Opin. Ther. Pat. 23 : 149-153.
11. Fang, Z. Y., R. Lin, B. X. Yuan, G. D. Yang, Y. Liu, and H. Zhang. Tanshinone IIA downregulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit. J. Ethnopharmacol. 115 : 217-222.
12. Chen, W., F. Tang, B. Xie, S. Chen, H. Huang, and P. Liu.2012. Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress. Eur. J. Pharmacol. 674 : 359-364.
13. Xu, S., P. J. Little, T. Lan, Y. Huang, K. Le, X. Wu, X. Shen, H. Huang, Y. Cai, F. Tang, et al.2011.Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet. Arch. Biochem. Biophys. 515 : 72-79.
14. Morita, T. 2005.Heme oxygenase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25 : 1786-1795.
15. Stocker, R., and M. A. Perrella.2006.Heme oxygenase-1: a novel drug target for atherosclerotic diseases? Circulation.114 : 2178-2189.
16. Orozco, L. D., M. H. Kapturczak, B. Barajas, X. Wang, M. M. Weinstein, J. Wong, J. Deshane, S. Bolisetty, Z. Shaposhnik, D. M. Shih, et al.2007.Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ. Res. 100 : 1703-1711.
17. Chen, T. H., Y. T. Hsu, C. H. Chen, S. H. Kao, and H. M. Lee.2007. Tanshinone IIA from Salvia miltiorrhiza induces heme oxygenase-1 expression and inhibits lipopolysaccharide-induced nitric oxide expression in RAW 264.7 cells. Mitochondrion.7 : 101-105.
18. Qi, Y. Y., L. Xiao, L. D. Zhang, S. H. Song, Y. Mei, T. Chen, J. M. Tang, F. Liu, G. S. Ding, Y. Z. Shi, et al.2012.Tanshinone IIA pretreatment attenuates hepatic ischemia-reperfusion. Front. Biosci. (Elite Ed.).4 : 1303-1313.
19. Gu, X., B. Trigatti, S. Xu, S. Acton, J. Babitt, and M. Krieger.1998. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J. Biol. Chem. 273 : 26338-26348.
20. Gong, Z., C. Huang, X. Sheng, Y. Zhang, Q. Li, M. W. Wang, L. Peng, and Y. Q. Zang.2009.The role of tanshinone IIA in the treatment of obesity through peroxisome proliferator-Activated receptor gamma antagonism. Endocrinology.150 : 104-113.
21. Xu, S., Z. Liu, Y. Huang, K. Le, F. Tang, H. Huang, S. Ogura, P. J. Little, X. Shen, and P. Liu.2012.Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-kappaB activation. Transl. Res. 160 : 114-124.
22. Robinet, P., Z. Wang, S. L. Hazen, and J. D. Smith.2010.A simple and sensitive enzymatic method for cholesterol quantification in macrophages and foam cells. J. Lipid Res. 51 : 3364-3369.
23. Lin, S., C. Zhou, E. Neufeld, Y. H. Wang, S. W. Xu, L. Lu, Y. Wang, Z. P. Liu, D. Li, C. Li, et al.2013.BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein modulates ATP-binding cassette transporter A-1 trafficking and function. Arterioscler. Thromb. Vasc. Biol. 33 : e31-e38.
24. Zhou, S. G., S. F. Zhou, H. Q. Huang, J. W. Chen, M. Huang, and P. Q. Liu.2006.Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats. J. Proteome Res. 5 : 2901-2908.
25. Horvai, A., W. Palinski, H. Wu, K. S. Moulton, K. Kalla, and C. K. Glass.1995.Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA.92 : 5391-5395.
26. Moulton, K. S., K. Semple, H. Wu, and C. K. Glass.1994.Cellspecific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif. Mol. Cell. Biol. 14 : 4408-4418.
27. D'Autréaux, B., and M. B. Toledano.2007.ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8 : 813-824.
28. Niu, X. L., K. Ichimori, X. Yang, Y. Hirota, K. Hoshiai, M. Li, and H. Nakazawa.2000.Tanshinone II-A inhibits low density lipoprotein oxidation in vitro. Free Radic. Res. 33 : 305-312.
29. Jang, S. I., H. J. Kim, Y. J. Kim, S. I. Jeong, and Y. O. You.2006. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK, p38 and JNK pathways. Eur. J. Pharmacol. 542 : 1-7.
30. Li, X., J. R. Du, Y. Yu, B. Bai, and X. Y. Zheng.2010.Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway. J. Ethnopharmacol. 129 : 273-279.
31. Jin, U. H., S. J. Suh, H. W. Chang, J. K. Son, S. H. Lee, K. H. Son, Y. C. Chang, and C. H. Kim.2008.Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP-9 activity through AKT signaling pathway. J. Cell. Biochem. 104 : 15-26.
32. Tang, F., X. Wu, T. Wang, P. Wang, R. Li, H. Zhang, J. Gao, S. Chen, L. Bao, H. Huang, et al.2007.Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascul. Pharmacol. 46 : 427-438.
33. Kunjathoor, V. V., M. Febbraio, E. A. Podrez, K. J. Moore, L. Andersson, S. Koehn, J. S. Rhee, R. Silverstein, H. F. Hoff, and M. W. Freeman.2002. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277 : 49982-49988.
34. Febbraio, M., E. A. Podrez, J. D. Smith, D. P. Hajjar, S. L. Hazen, H. F. Hoff, K. Sharma, and R. L. Silverstein.2000.Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105 : 1049-1056.
35. Suzuki, H., Y. Kurihara, M. Takeya, N. Kamada, M. Kataoka, K. Jishage, O. Ueda, H. Sakaguchi, T. Higashi, T. Suzuki, et al.1997.A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature.386 : 292-296.
36. McNeish, J., R. J. Aiello, D. Guyot, T. Turi, C. Gabel, C. Aldinger, K. L. Hoppe, M. L. Roach, L. J. Royer, J. de Wet, et al.2000.High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. USA.97 : 4245-4250.
37. Kennedy, M. A., G. C. Barrera, K. Nakamura, A. Baldan, P. Tarr, M. C. Fishbein, J. Frank, O. L. Francone, and P. A. Edwards.2005.ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1 : 121-131.
38. Trigatti, B., H. Rayburn, M. Vinals, A. Braun, H. Miettinen, M. Penman, M. Hertz, M. Schrenzel, L. Amigo, A. Rigotti, et al.1999.Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc. Natl. Acad. Sci. USA.96 : 9322-9327.
39. Li, A. C., and C. K. Glass.2004.PPAR-And LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J. Lipid Res. 45 : 2161-2173.
40. Calkin, A. C., and P. Tontonoz.2010.Liver x receptor signaling pathways and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30 : 1513-1518.
41. Yang, X. P., L. A. Freeman, C. L. Knapper, M. J. Amar, A. Remaley, H. B. Brewer, Jr. ., and S. Santamarina-Fojo.2002.The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene. J. Lipid Res. 43 : 297-306.
42. Iwamoto, N., S. Abe-Dohmae, M. Ayaori, N. Tanaka, M. Kusuhara, F. Ohsuzu, and S. Yokoyama.2007.ATP-binding cassette transporter A1 gene transcription is downregulated by activator protein 2alpha. Doxazosin inhibits activator protein 2alpha and increases high-density lipoprotein biogenesis independent of alpha1-Adrenoceptor blockade. Circ. Res. 101 : 156-165.
43. Chen, X., Y. Zhao, Z. Guo, L. Zhou, E. U. Okoro, and H. Yang.2011.Transcriptional regulation of ATP-binding cassette transporter A1 expression by a novel signaling pathway. J. Biol. Chem. 286 : 8917-8923.
44. Juan, S. H., T. S. Lee, K. W. Tseng, J. Y. Liou, S. K. Shyue, K. K. Wu, and L. Y. Chau.2001.Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation.104 : 1519-1525.
45. Kang, K. W., S. J. Lee, and S. G. Kim.2005.Molecular mechanism of nrf2 activation by oxidative stress. Antioxid. Redox Signal. 7 : 1664-1673.
46. Kim, Y. M., H. O. Pae, J. E. Park, Y. C. Lee, J. M. Woo, N. H. Kim, Y. K. Choi, B. S. Lee, S. R. Kim, and H. T. Chung.2011.Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 14 : 137-167.
47. Xu, C., X. Yuan, Z. Pan, G. Shen, J. H. Kim, S. Yu, T. O. Khor, W. Li, J. Ma, and A. N. Kong.2006.Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol. Cancer Ther. 5 : 1918-1926.
48. Rushworth, S. A., R. M. Ogborne, C. A. Charalambos, and M. A. O'Connell.2006.Role of protein kinase C delta in curcumininduced antioxidant response element-mediated gene expression in human monocytes. Biochem. Biophys. Res. Commun. 341 : 1007-1016.
49. Gong, P., B. Hu, and A. I. Cederbaum.2004.Diallyl sulfide induces heme oxygenase-1 through MAPK pathway. Arch. Biochem. Biophys. 432 : 252-260.
50. Nguyen, T., P. J. Sherratt, H. C. Huang, C. S. Yang, and C. B. Pickett.2003.Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J. Biol. Chem. 278 : 4536-4541.
51. Sussan, T. E., J. Jun, R. Thimmulappa, D. Bedja, M. Antero, K. L. Gabrielson, V. Y. Polotsky, and S. Biswal.2008.Disruption of Nrf2, a key inducer of antioxidant defenses, attenuates ApoE-mediated atherosclerosis in mice. PLoS ONE.3 : e3791.
52. Barajas, B., N. Che, F. Yin, A. Rowshanrad, L. D. Orozco, K. W. Gong, X. Wang, L. W. Castellani, K. Reue, A. J. Lusis, et al.2011.NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection. Arterioscler. Thromb. Vasc. Biol. 31 : 58-66.